← Back to institutional beliefs timeline

Institutional belief · Emergency cardiology and treatment guidelines

Routine oxygen for uncomplicated heart attacks

Supplemental oxygen was professionally recommended for routine early use in uncomplicated heart-attack patients even when blood oxygen was not low, because raising available oxygen was expected to help ischemic heart muscle.

1 episode

Current understanding

Current understanding

Supplemental oxygen is indicated for acute coronary syndrome when hypoxemia or respiratory compromise is present. In patients whose oxygen saturation is already at least 90%, randomized trials have not shown cardiovascular benefit from routine oxygen, and current U.S. guidelines recommend against it.

Consequences and human impact

Consequences and human impact

Oxygen became a reflexive part of heart-attack care despite weak evidence for normoxic patients. Professional guidelines helped preserve that practice into the twenty-first century. Trials later showed no improvement in survival or recurrent infarction, while hyperoxia can increase coronary vascular resistance and oxidative stress.

How the consequences followed

The 2004 recommendation was Class IIa with Level of Evidence C: it said routine oxygen was reasonable, not mandatory, and rested mainly on expert judgment rather than strong outcome trials.

Oxygen remains an essential treatment for hypoxemia and respiratory distress. The corrected proposition concerns automatic oxygen for patients whose blood is already adequately oxygenated.

2004

ACC/AHA STEMI guideline said oxygen for all uncomplicated patients during the first six hours was reasonable

6,629

Patients in the DETO2X-AMI randomized trial of routine oxygen versus ambient air

2025

U.S. ACS guideline classified routine oxygen at saturation 90% or higher as Class III — No Benefit

Quantitative figures are highlighted only when the cited evidence supports them. The scale of a related catastrophe is not automatically treated as a death toll caused solely by this belief.

Institutional episode

United States

2004–2013Officially endorsed

The routine oxygen mask survived because the physiology sounded obvious: an obstructed coronary artery was starving myocardium of oxygen, so supplying more oxygen seemed protective. The 2004 ACC/AHA STEMI guideline still called oxygen for every uncomplicated patient during the first six hours reasonable, although the evidence level was only C. By 2013 the same guideline process openly acknowledged the lack of supporting data and possible harm. DETO2X-AMI then randomized 6,629 patients and found no mortality or reinfarction benefit. Current ACC/AHA guidance gives routine oxygen in ACS patients with saturation of at least 90% a Class III 'No Benefit' recommendation.

Institutions

  • American College of Cardiology
  • American Heart Association

Documented consequences

  • Professional guidance reinforced routine oxygen use in normoxic heart-attack patients despite the absence of strong evidence that it improved clinical outcomes
  • Patients could receive unnecessary oxygen even when hemoglobin was already adequately saturated
  • Hyperoxia can increase coronary vascular resistance and oxidative stress, creating plausible mechanisms of harm without demonstrated compensating benefit in normoxic patients
  • Large randomized trials later found no reduction in mortality or recurrent myocardial infarction from routine oxygen in patients without hypoxemia

Institutional machinery

The 2004 ACC/AHA guideline for ST-elevation myocardial infarction gave a Class IIa recommendation that supplemental oxygen was reasonable for all patients with uncomplicated STEMI during the first six hours, while separately giving a Class I recommendation for patients with oxygen saturation below 90%. By 2013 the STEMI guideline acknowledged that few data supported or refuted routine oxygen, cited a pooled signal of possible harm and emphasized oxygen for hypoxemia. Subsequent trials made the shift more definitive.

Sources and what they establish

Last reviewed: 27/08/2026